Eolas Medical raises £8.9m in Series A funding led by Acton Capital to scale its NHS knowledge platform
The Series A round was led by Acton Capital to accelerate artificial intelligence features and international growth.
Eolas Medical is a clinician-led health technology company that provides digital knowledge platforms for frontline NHS teams. Its web and mobile applications help healthcare professionals access local guidance and policies quickly.
Eolas Medical has secured £8.9m in Series A funding led by Acton Capital to scale its healthcare knowledge platform. The fresh capital will be deployed to accelerate the rollout of artificial intelligence features and support broader international expansion as demand increases for clinical decision support tools.
The Belfast and London-based firm provides a searchable source of truth that replaces traditional intranets across numerous clinical sites. By offering plain-language search capabilities tied to internal hospital resources, the platform aims to reduce administrative friction and support safe decision-making in acute care settings.
From the founder
"Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it. This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely – particularly in the winter. As AI develops, the next phase is about making that access even more usable, so staff can ask a question and get a clear, evidence-backed answer straight away, in plain language."
Declan Kelly
founder and CEO at Eolas Medical
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
Eolas Medical
Eolas Medical provides trusted knowledge access platforms for frontline healthcare professionals.